Untargeted plasma metabolomics identifies metabolite signatures associated with suicidality status in chronic schizophrenia
Authors:
- 30 August 2026
- journal article
- research article
- Published by Springer Nature in European Archives of Psychiatry and Clinical Neuroscience
- Vol. 276 (7) , 3935-3948
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82371512)
- National Natural Science Foundation of China (82571719)
- the Tianjin Key Medical Discipline Construction Project (TJYXZDXK-3-015B)
This publication has 48 references indexed in Scilit:
- Clinical predictors of suicidal ideation, suicide attempts and suicide death in depressive disorder: a systematic review and meta-analysisEuropean Archives of Psychiatry and Clinical Neuroscience, 2023
- Measurement of brain glutathione with magnetic Resonance spectroscopy in Schizophrenia-Spectrum disorders — A systematic review and Meta-AnalysisBrain, Behavior, and Immunity, 2023
- Stress induces major depressive disorder by a neutral sphingomyelinase 2-mediated accumulation of ceramide-enriched exosomes in the blood plasmaJournal of Molecular Medicine, 2022
- Mortality in people with schizophrenia: a systematic review and meta‐analysis of relative risk and aggravating or attenuating factorsWorld Psychiatry, 2022
- The critical distinction between suicidal ideation and suicide attemptsWorld Psychiatry, 2021
- Schizophrenia—An OverviewJAMA Psychiatry, 2020
- Variable influence on projection (VIP) for orthogonal projections to latent structures (OPLS)Journal of Chemometrics, 2014
- Sphingolipids in Psychiatric Disorders and Pain Syndromes2013
- Double-check: validation of diagnostic statistics for PLS-DA models in metabolomics studiesMetabolomics, 2011
- The Lifetime Risk of Suicide in SchizophreniaArchives of General Psychiatry, 2005